The present invention relates to the use of standardized extract of Tinosporacordifolia as an immunoadjuvant in the treatment of renal disorders such asnephrotic syndrome and chronic recurrent urinary tract infections, bothcomplicated and uncomplicated. The present invention also relates topharmaceutical compositions comprising the standardized extract of Tinosporacordifolia. The present invention further relates to a method of treatment ofrenal disorders such as recurrent urinary tract infection particularlyoccurring due to relapsing E. coli, Klebsiella and other gram negativeinfections and to a method of treatment of nephrotic syndrome usingstandardized extract of Tinospora cordifolia as an immunoadjuvant inconjunction with conventional therapy.
